Postmenopausal state
Item
postmenopausal as defined by nccn (any of the following)
boolean
C0232970 (UMLS CUI [1])
Bilateral oophorectomy
Item
prior bilateral oophorectomy
boolean
C0278321 (UMLS CUI [1])
Age
Item
age equal to or greater then 60 years of age
boolean
C0001779 (UMLS CUI [1])
Age | Amenorrhea Duration | Chemotherapy Absent | Tamoxifen Absent | Toremifene Absent | Ovarian suppression Absent | FSH measurement in range Postmenopausal state | Estradiol measurement in range Postmenopausal state
Item
age less then 60 and amenorrheic for 12 or more months in the absence of chemotherapy, tamoxifen, toremifene or ovarian suppression and fsh and estradiol in the postmenopausal range
boolean
C0001779 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0039286 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0076836 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0677922 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0202022 (UMLS CUI [7,1])
C0460094 (UMLS CUI [7,2])
C0232970 (UMLS CUI [7,3])
C0337434 (UMLS CUI [8,1])
C0460094 (UMLS CUI [8,2])
C0232970 (UMLS CUI [8,3])
Tamoxifen | Toremifene | Age | FSH measurement in range Postmenopausal state | Plasma estradiol measurement in range Postmenopausal state
Item
if taking tamoxifen or toremifene and age less then 60y, then fsh and plasma estradiol level in postmenopausal ranges71.
boolean
C0039286 (UMLS CUI [1])
C0076836 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C0202022 (UMLS CUI [4,1])
C0460094 (UMLS CUI [4,2])
C0232970 (UMLS CUI [4,3])
C1277973 (UMLS CUI [5,1])
C0460094 (UMLS CUI [5,2])
C0232970 (UMLS CUI [5,3])
Capability Informed Consent | Survey instrument Completion
Item
individuals capable of consenting and self administering the survey instrument.
boolean
C2698977 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0038951 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Teeth Quantity Present
Item
at least 15 teeth present.
boolean
C0040426 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,3])
Aromatase Inhibitors Use
Item
ai users:
boolean
C0593802 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
Breast Carcinoma TNM Breast tumor staging | Neoplasm Metastasis Absent
Item
diagnosis of bca- histologic confirmed diagnosis of bca: stage 0, i, ii, or iii with no evidence of metastatic disease.
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Indication Aromatase Inhibitors | anastrozole | exemestane | letrozole | Tamoxifen | Raloxifene | Chemotherapy | Therapeutic radiology procedure
Item
treatment- ai as clinically indicated (ai may be anastrozole, exemestane or letrozole). subjects may have had prior tamoxifen or raloxifene. subjects may have had chemotherapy and/or radiation therapy. must be within the first year of consecutive ai therapy. if a subject started ai, discontinued, then restarted, they will be accepted into the study as long as the past therapy did not exceed 12 months and the current therapy has not exceeded 12 months.
boolean
C3146298 (UMLS CUI [1,1])
C0593802 (UMLS CUI [1,2])
C0290883 (UMLS CUI [2])
C0851344 (UMLS CUI [3])
C0246421 (UMLS CUI [4])
C0039286 (UMLS CUI [5])
C0244404 (UMLS CUI [6])
C0392920 (UMLS CUI [7])
C1522449 (UMLS CUI [8])
Control Group
Item
controls:
boolean
C0009932 (UMLS CUI [1])
Malignant Neoplasm Absent | Exception Malignant neoplasm of thyroid | Exception Skin carcinoma
Item
no diagnosis of cancer.- patients must not have a diagnosis of any cancer (not including a history of thyroid or skin cancer).
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007115 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
Secondary malignant neoplasm of female breast
Item
metastatic bca (ai treated group: fully resected locally recurrent disease is permitted if the patient has been rendered without evidence of disease).
boolean
C0346993 (UMLS CUI [1])
Mental disorders Exclude Completion Questionnaires | Social situation Excludes Completion Questionnaires
Item
significant psychiatric illness/social situations that would preclude completion of questionnaires
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0034394 (UMLS CUI [1,4])
C0748872 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C0034394 (UMLS CUI [2,4])
Pharmaceutical Preparations chronic Affecting Periodontal Index | Calcium Channel Blockers | Anticonvulsants | Immunosuppressive Agents | Prednisone U/day | NSAIDs allowed | Diphosphonates allowed
Item
chronic medications known to affect the periodontal status (calcium antagonist, anti-convulsives, immunosuppressives (> prednisone 7.5mg daily). nsaids and bisphosphonates are permitted.
boolean
C0013227 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0031092 (UMLS CUI [1,4])
C0006684 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
C0021081 (UMLS CUI [4])
C0032952 (UMLS CUI [5,1])
C0456683 (UMLS CUI [5,2])
C0003211 (UMLS CUI [6,1])
C0683607 (UMLS CUI [6,2])
C0012544 (UMLS CUI [7,1])
C0683607 (UMLS CUI [7,2])
Premedication Condition Requirement Antibiotic therapy | Evaluation Special
Item
premedication- conditions that require antibiotic therapy will be evaluated on a case-by-case basis. (patients taking prophylaxis for joint replacements will not be excluded.)
boolean
C0033045 (UMLS CUI [1,1])
C0348080 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0338237 (UMLS CUI [1,4])
C1261322 (UMLS CUI [2,1])
C0205555 (UMLS CUI [2,2])